Literature DB >> 10839732

Chlamydia pneumoniae in atherosclerotic tissue.

D Taylor-Robinson1, B J Thomas.   

Abstract

The majority of almost 30 publications from 1992 to 1999 describe Chlamydia pneumoniae organisms in atherosclerotic lesions of various major arteries. In the first study in the United Kingdom, C. pneumoniae was found in the aorta and femoral and iliac arteries. In a subsequent study, the organism was detected in arteries of subjects as young as 15 years. In a collaborative investigation, 71% of atheromatous arteries taken at autopsy from white South African subjects were C. pneumoniae positive compared with 9% of nonatheromatous arteries. Of interest, the organisms were detected in 67% of vessels that showed only early atherosclerotic lesions (fatty streaks). C. pneumoniae was also found in the ruptured coronary artery plaque of a black South African who died of myocardial infarction, a rare event. The presence of C. pneumoniae organisms within foam and smooth muscle cells of atherosclerotic plaques is beyond doubt, but their role in atherosclerosis remains enigmatic.

Entities:  

Mesh:

Year:  2000        PMID: 10839732     DOI: 10.1086/315614

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression.

Authors:  Peiyi Fan; Feng Dong; Yanqing Huang; Guangming Zhong
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Pathohistological changes in diffuse coronary atherosclerosis and chronic infection caused by Chlamydia pneumonia.

Authors:  Mateja Legan; Olga Vraspir-Porenta; Karja Kese; Ruda Zorc-Plesković; Marjeta Zorc
Journal:  Bosn J Basic Med Sci       Date:  2004-02       Impact factor: 3.363

3.  Correlation between rises in Chlamydia pneumoniae-specific antibodies, platelet activation and lipid peroxidation after percutaneous coronary intervention.

Authors:  H Kälvegren; J Fridfeldt; P Garvin; L Wind; P Leanderson; M Kristenson; E Kihlström; T Bengtsson; A Richter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-19       Impact factor: 3.267

4.  Signaling events in pathogen-induced macrophage foam cell formation.

Authors:  Yazdani B Shaik-Dasthagirisaheb; Samrawit Mekasha; Xianbao He; Frank C Gibson; Robin R Ingalls
Journal:  Pathog Dis       Date:  2016-07-31       Impact factor: 3.166

5.  Characterization of a streptococcal endopeptidase with homology to human endothelin-converting enzyme.

Authors:  J Oetjen; P Fives-Taylor; E Froeliger
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols.

Authors:  Petra Apfalter; Ojan Assadian; Francesco Blasi; Jens Boman; Charlotte A Gaydos; Michael Kundi; Athanasios Makristathis; Marion Nehr; Manfred L Rotter; Alexander M Hirschl
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Chlamydia pneumoniae in infrequently examined blood vessels.

Authors:  D Taylor-Robinson; B J Thomas; R Goldin; R Stanbridge
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

8.  High rate of in-stent restenosis after coronary intervention in carriers of the mutant mannose-binding lectin allele.

Authors:  Zsolt Bagyura; Loretta Kiss; Balázs Berta; Ágnes Szilágyi; Kristóf Hirschberg; Gábor Széplaki; Árpád Lux; Zsolt Szelid; Pál Soós; Béla Merkely
Journal:  BMC Cardiovasc Disord       Date:  2017-01-05       Impact factor: 2.298

9.  Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair.

Authors:  Tina Mygind; Lars Østergaard; Svend Birkelund; Jes S Lindholt; Gunna Christiansen
Journal:  BMC Microbiol       Date:  2003-09-02       Impact factor: 3.605

10.  Limited role for C. pneumoniae, CMV and HSV-1 in cerebral large and small vessel atherosclerosis.

Authors:  M Voorend; A J A M van der Ven; B Kubat; J Lodder; C A Bruggeman
Journal:  Open Neurol J       Date:  2008-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.